Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Aug 1;9(4):101.
doi: 10.3390/geriatrics9040101.

Lung Cancer: New Directions in Senior Patients Assessment

Anca Iuliana Pîslaru  1 , Sabinne-Marie Albișteanu  1 , Adina Carmen Ilie  1 , Ramona Ștefaniu  1 , Aurelia Mârza  1 , Ștefan Moscaliuc  2 , Mălina Nicoară  2 , Ana-Maria Turcu  1 , Gabriela Grigoraș  1 , Ioana Dana Alexa  1
Affiliations
Review

Lung Cancer: New Directions in Senior Patients Assessment

Anca Iuliana Pîslaru et al. Geriatrics (Basel). .

Abstract

Age is but one significant prognostic factor in lung cancer, influencing survival, treatment response, and outcomes. This narrative review synthesizes findings from searches of 11 leading databases of research studies, systematic reviews, book chapters, and clinical trial reports on lung cancer in senior patients, with a focus on geriatric assessment as well as biomarkers. Key prognostic factors for lung cancer in seniors include biological age, functional capability, physical and psychological comorbidities, frailty, nutrition, status, and biomarkers like DNA methylation age. We identified the most valuable assessments that balance efficacy with quality of life. Optimizing care and improving outcomes with senior lung cancer patients benefits from a tailored therapeutic approach incorporating a complex geriatric assessment. A multidisciplinary collaboration between geriatricians, oncologists, and pulmonologists is crucial.

Keywords: biomarkers; frailty; geriatric assessment; lung cancer; senior patients.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Similar articles

See all similar articles

References

    1. Abraham J., Gulley J.L., Allegra C.J., editors. Bethesda Handbook of Clinical Oncology. Lippincott Williams & Wilkins; Philadelphia, PA, USA: 2000.
    1. Yang C.J., Brown A.B., Deng J.Z., Lui N.S., Backhus L.M., Shrager J.B., D’Amico T.A., Berry M.F. The Oldest Old: A National Analysis of Outcomes for Patients 90 Years or Older with Lung Cancer. Ann. Thorac. Surg. 2020;109:350–357. doi: 10.1016/j.athoracsur.2019.09.027. - DOI - PubMed
    1. Lee-Chiong T.L., Jr., Matthay R.A. Lung cancer in the elderly patient. Clin. Chest Med. 1993;14:453–478. doi: 10.1016/S0272-5231(21)00909-6. - DOI - PubMed
    1. Wang P., Li C., An Y., Wang X., Liang Z., Chen L. The management of elderly patients with lung cancer: A single center retrospective study. Ann. Palliat. Med. 2021;10:229–237. doi: 10.21037/apm-20-2125. - DOI - PubMed
    1. Niederhuber J.E., Armitage J.O., Doroshow J.H., Kastan M.B., Tepper J.E. Abeloff’s Clinical Oncology e-Book. Elsevier Health Sciences; Amsterdam, The Netherlands: 2013.

Grants and funding

This research received no external funding.

LinkOut - more resources